Advertisement

Piramal Pharma Solutions to acquire G&W Laboratories'' drug manufacturing facility in US

Follow The Hawk on Google News+ Follow

Advertisement

New Delhi: Piramal Enterprises Ltd''s pharma solutions business on Saturday said it has entered into a pact with G&W Laboratories Inc to acquire its solid oral dosage drug product manufacturing facility at Sellersville in US for USD 17.5 million (over Rs 130 crore).

"According to the terms of the agreement, Piramal Enterprises Ltd, through one of its affiliates, would acquire...100 per cent stake in the entity that operates the facility and owns the related real estate," Piramal Pharma Solutions (PPS) said in a statement.

Advertisement

This acquisition broadens the offering of Piramal Pharma Solutions by adding solid oral dosage form capabilities in North America. Until now, its capabilities in solid oral dosage forms were all located in the UK and India, it added.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"The Sellersville site can also produce liquids, creams, and ointments, further expanding the PPS portfolio," the statement said.

The site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), it added.

Advertisement

"Many of our customers are looking for US-based manufacturing partners to expand and support their pipeline. This acquisition strengthens our ability to partner with them on best-in-class drug products," PPS CEO Peter DeYoung said.

Piramal Pharma Solutions now offers solid oral drug product development and commercial manufacturing in all its major geographies, addressing a previously unmet customer need and strengthening its ability to work globally with customers to reduce the burden of disease on patients, he added.

The company expects to further grow the site''s current strength to support development services as well as any COVID-19 management drug opportunities, the statement said. PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST